To verify whether the anti-obesity effect of KS-40070 is the result of specifically inhibiting DYRK1B, a siRNA-based knock-down assay was performed to specifically inhibit DYKR1B expression (Figure 4). This evidence concerns the gene DYRK1B and Obesity.